ABTC (28) GAIN (49) FWDI (26) VEL (59) ⌘ Pro Terminal →

HIVE Digital Technologies Ltd. (HIVE) — RQD Stock Rating Cockpit

Q: Should I buy, hold, or sell HIVE stock right now?

HIVE Digital Technologies Ltd. (HIVE) currently earns a Roarable Rating of D+ (Sell — SELL) with 52/100 RQD Confidence. Stretched risk/reward at current multiples (-27% return on capital) under elevated 10-year interest-rate pressure.

Q: What is HIVE's 12-month price target and RQD AI Jury consensus?

HIVE's 12-month base price target is $2.01 (range $1.57 to $5.87), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

$2.07 -2.36% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

HIVE Digital Technologies Ltd. (HIVE) carries a Roarable Rating of D+ (Sell) with 52/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D+ • SELL / AVOID Cap $567.8M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk C

Each axis scored 0–20

12M PRICE TARGET CONE-2.9% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for HIVE)Realized 20D OHLCV Swing Band: ±12.5%

RSI-14 MOMENTUMOVERSOLD (<32)

30.530 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

3.80>3.0 Fortress Safe

PIOTROSKI F-SCORESOLID CORE (5–6)

5 / 99-Pt Accounting

52-WEEK LASER RANGE9% OF RANGE

L: $2$2.07H: $6

1. Money & Cash Health● MIXED

Are profits real cash in the bank?

Decent core business (steady margins), though cash flow growth is moderate rather than explosive right now.

Factor Grade: D+RQD 11 / 20

2. Big Money & Insiders● TRIMMING

Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: D-RQD 16 / 40

3. Hidden Risks & Market Weather● WATCH

SEC fine-print scan & interest-rate fit

No major SEC filing blowups, though current interest rates and Fed liquidity call for normal position sizing.

Factor Grade: CRQD 25 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

JEV AI Jury Split (Battleground) on HIVE

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

NEUTRAL (55)

-26.5% ROIC with 42.0% gross margin and 10.98% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

NEUTRAL (55)

Altman-Z 4.20 and Piotroski 5/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BEARISH (50)

16/40 institutional & smart-money positioning score with 14/20 macro alignment.

Bull Case: Why Buyers Like HIVE

✓Established market leader in Financials with deep daily trading liquidity.

Bear Case: What Could Go Wrong

!Company executives have done more routine share selling than personal cash buying lately.
!Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring HIVE)

✓Walkthrough of HIVE's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

HIVE // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -14.11%▼ DESCENDING CHANNEL

2026-10-30O $1.94H $2.07L $1.82C $2.07VOL 19.00M

RES: $2.80SUP: $0.69SMA50: $2.72SMA200: $2.83

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

HIVE Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 HIVE Butterfly Map → + Track HIVE →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +158.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on HIVE today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for HIVE. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for HIVE today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HIVE)

Financials Rank #766 of 1096 ⚔️ ABTC vs HIVE Full Matrix →

1. Head-to-Head Financials Peer Comparison (HIVE vs. ABTC, GAIN, FWDI, VEL)

Industry: Finance: Consumer Services (156 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, HIVE Digital Technologies Ltd. (HIVE) ranks #766 by composite RQD confidence (52/100, grade D+) and #674 by equity capitalization ($567.8M). Within this direct 5-issuer industry benchmark cohort, VEL leads on earnings valuation at 6.0x trailing P/E, while GAIN leads on capital efficiency and profitability with 31.0% ROIC and — gross margin. VEL currently holds the highest overall quantitative score in the immediate peer group at 59/100 (C-) compared with HIVE at 52/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
HIVE ACTIVE HIVE Digital Technologies Ltd.	D+	52/100	—	—	-26.5%	-2.36%	$567.8M	Benchmark Subject
ABTC American Bitcoin Corp. (Class A)	E	28/100	—	—	-27.1%	-5.90%	$546.1M	/abtc-vs-hive →
GAIN Gladstone Investment Corporation Business Development Company	D	49/100	—	—	31.0%	+1.26%	$608.1M	/gain-vs-hive →
FWDI Forward Industries Inc.	E	26/100	—	—	-0.8%	-4.54%	$529.4M	/fwdi-vs-hive →
VEL Velocity Financial Inc.	C-	59/100	6.0x	—	15.6%	+2.44%	$629.7M	/vel-vs-hive →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2026-03-31 • CIK 0001720424

In its most recent audited fiscal period (FY2025, filed 2026-03-31), HIVE Digital Technologies Ltd. (HIVE) reported GAAP revenue of $297.8M (+158.3% vs. FY2024 revenue of $115.3M , and +160.2% cumulative change since FY2023) , GAAP net income of -$148.4M, operating cash flow of $62.3M, and free cash flow of $62.3M (+274.8% YoY). On the balance sheet, HIVE closed FY2025 with $624.0M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2026-03-31	$297.8M	-$148.4M	$62.3M	$62.3M	$624.0M	—
FY2024 (FY)	2025-03-31	$115.3M	-$3.0M	$16.6M	$16.6M	—	—
FY2023 (FY)	2024-03-31	$114.5M	$26.5M	$9.6M	$9.6M	—	—

3. HIVE Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is HIVE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, HIVE Digital Technologies Ltd. (NASDAQ: HIVE) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 52/100 at a spot price of $2.07 (-2.36% 1D, market cap $567.8M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 14/20, and SEC Balance-Sheet Forensics 9/20. Across 1096 tracked Financials issuers, HIVE ranks #766 in composite RQD confidence.

How does HIVE compare to ABTC and GAIN in the Financials sector?

Within the Financials sector (Finance: Consumer Services), HIVE carries a Roarable D+ (52/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -26.5%. By comparison, ABTC (American Bitcoin Corp. (Class A)) holds a E grade (28/100 RQD, P/E N/A, ROIC -27.1%, cap $546.1M) and GAIN (Gladstone Investment Corporation Business Development Company) posts a D grade (49/100 RQD, P/E N/A, ROIC 31.0%, cap $608.1M). Among the 5-stock peer group, VEL leads on earnings multiple (6.0x) while GAIN leads on capital efficiency (31.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for HIVE?

Per HIVE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0001720424), HIVE Digital Technologies Ltd. generated $297.8M in revenue (+158.3% YoY), -$148.4M in net income, and $62.3M in free cash flow against $624.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is HIVE trading relative to its 50-day, 200-day, and 52-week technical levels?

HIVE last traded at $2.07 (-2.36% on volume of 8,468,254 shares), positioning the stock -23.90% below its 50-day simple moving average ($2.72) and -26.86% below its 200-day simple moving average ($2.83). Across its 52-week range of $1.73 to $5.59, HIVE sits at the 8.8% percentile with a 14-day RSI of 30.5 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.81 to $2.33).

HIVE Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell HIVE stock right now?

HIVE Digital Technologies Ltd. (HIVE) currently earns a Roarable Rating of D+ (Sell — SELL) with 52/100 RQD Confidence. Stretched risk/reward at current multiples (-27% return on capital) under elevated 10-year interest-rate pressure.

What is HIVE's 12-month price target and RQD AI Jury consensus?

HIVE's 12-month base price target is $2.01 (range $1.57 to $5.87), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: HIVE RQD Cockpit HIVE 12M Forecast HIVE Earnings & Move HIVE Dividends & DRIP HIVE Insiders & 13F HIVE Whale Options HIVE Profit Sankey HIVE News & Why